Upregulated HAPLN promotes peritoneal dissemination [107] and elevated expression of HAPLN1 in CAFs is associated with an aggressive phenotype, poor prognosis, and tumour progression in GC [109]. This evidence concerns the gene HAPLN1 and gastric cancer.